Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 3Genitourinary 1Gastrointestinal 1Endocrine 1

Conditions

Motor Activity 3Breast Neoplasms 3Neoplasms 1Fatigue 1Arthralgia 1

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 486Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 152Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
methyl hydroxyethyl cellulose × Breast × Clear all
NCT02682836 2022-01-06

Physical Activity to Maintain Quality of Life and Physical Function in Women With Metastatic Breast Cancer: a Pilot Study

UNC Lineberger Comprehensive Cancer Center

Phase NA Completed
60 enrolled
Breast

Breast Neoplasms, Fatigue, Motor Activity

NCT02167932 2018-06-06

The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast Cancer

UNC Lineberger Comprehensive Cancer Center

Completed
127 enrolled
Breast

Breast Neoplasms, Motor Activity, Neoplasms

NCT01900418 2016-08-08

Physical Activity to Reduce Joint Pain During Aromatase Inhibitor Therapy

University of North Carolina, Chapel Hill

Phase NA Completed
78 enrolled
Breast

Breast Neoplasms, Motor Activity, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡